NCT00050349View on ClinicalTrials.gov

EPO906 in Carcinoid and Other Neuroendocrine Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
CarcinoidNeuroendocrine Tumors
Interventions
DRUG

EPO906 epothilone B

Trial Locations (5)

10021

Weill Medical College of Cornell Univ., New York

60611

Northwestern University, Chicago

70115

LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Deptof LSU Health Sciences (2), New Orleans

97201

Oregon Health Sciences University, Portland

52242-1091

University of Iowa Health Care, Iowa City

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY